NGS Sample Preparation Market 2026

November 2025 | 243 pages | ID: N87B206FB621EN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The NGS Sample Preparation Market was valued at in and is anticipated to reach by , at a CAGR of 0.19 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the NGS Sample Preparation Market.

This report delivers a comprehensive overview of the NGS Sample Preparation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NGS Sample Preparation Market. The NGS Sample Preparation Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

NGS Sample Preparation Market Scope:

By Product Type
  • Instruments and Kits
  • Reagents
  • Consumables
By Application
  • Disease Diagnostics
  • Drug Discovery
  • Agricultural and Animal Research
  • Others
By Technology
  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time (SMRT) Sequencing
  • Nanopore Sequencing
  • Others
By End user
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies
  • Contract research organization
  • Others
Key Players
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • F.Hoffmann-La Roche AG
  • QIAGEN N.V.
  • Twist Bioscience
  • Beckman Coulter
  • Tecan Trading AG
  • Pacific Biosciences of California, Inc.(LIST NOT EXHAUSTIVE)
Major Highlights

This report delivers a comprehensive overview of the NGS Sample Preparation Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NGS Sample Preparation Market. The NGS Sample Preparation Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Product Type
3.2. Market Snippet by Application
3.3. Market Snippet by Technology
3.4. Market Snippet by End User
3.5. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Emerging technologies empowering next-generation sequencing (NGS) of DNA are expected to drive market growth.
  4.1.2. Restraints:
    4.1.2.1. Challenges associated with NGS Sample preparation are expected to hamper the market growth.
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Unmet Needs

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Instruments and Kits*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Reagents
7.4. Consumables

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application Segment
8.2. Disease Diagnostics*
  8.2.1. Cancer Diagnostics
  8.2.2. Reproductive Health Diagnostics
  8.2.3. Infectious Disease Diagnostics
  8.2.4. Others
  8.2.5. Introduction
  8.2.6. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Drug Discovery
8.4. Agricultural and Animal Research
8.5. Others

9. BY TECHNOLOGY

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  9.1.2. Market Attractiveness Index, By Technology Segment
9.2. Sequencing by Synthesis (SBS)*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Ion Semiconductor Sequencing
9.4. Single-molecule Real-time (SMRT) Sequencing
9.5. Nanopore Sequencing
9.6. Others

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospitals & Clinics*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract research organization
10.5. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch

13. COMPANY PROFILES

13.1. Illumina, Inc.*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Agilent Technologies, Inc.
13.3. Thermo Fisher Scientific Inc.
13.4. PerkinElmer, Inc.
13.5. F.Hoffmann-La Roche AG
13.6. QIAGEN N.V.
13.7. Twist Bioscience
13.8. Beckman Coulter
13.9. Tecan Trading AG
13.10. Pacific Biosciences of California, Inc.(*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us


More Publications